CRWRF:OTC-Craneware plc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 27.86

Change

0.00 (0.00)%

Market Cap

USD 1.01B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-12 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
PMCUF Pro Medicus Limited

N/A

USD 8.05B
MTHRF M3 Inc

N/A

USD 7.77B
MTHRY M3 Inc

-0.17 (-3.21%)

USD 6.71B
PANHF Ping An Healthcare and Technol..

N/A

USD 1.67B
SMSZF SMS Co. Ltd

N/A

USD 1.09B
SUSRF Surgical Science Sweden AB (pu..

N/A

USD 0.71B
RSLBF RaySearch Laboratories AB (pub..

N/A

USD 0.44B
KSIOF kneat.com inc.

+0.01 (+0.32%)

USD 0.27B
VHIBF Vitalhub Corp

+0.11 (+2.10%)

USD 0.26B
AMJT AMJ Global Technology

N/A

USD 0.16B

ETFs Containing CRWRF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 39.30% 73% C 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.30% 72% C 85% B
Trailing 12 Months  
Capital Gain 48.59% 87% B+ 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 48.59% 87% B+ 86% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.38% 59% D- 47% F
Dividend Return 4.48% 58% F 43% F
Total Return 0.10% 14% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 34.09% 82% B 66% D+
Risk Adjusted Return 13.13% 68% D+ 47% F
Market Capitalization 1.01B 93% A 70% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.